Paul Tudor Jones’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Paul Tudor Jones’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-279,500	Closed	-$60.6M	–	2154
2021 Q1	$60.6M	Buy	+279,500	New	+$52.5M	1.22%	10
2017 Q1	–	Sell	-1,958	Closed	-$219K	–	1609
2016 Q4	$219K	Buy	+1,958	New	+$236K	0.01%	1183

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Paul Tudor Jones's GWPH Position: Q2 2021 in Review

Paul Tudor Jones sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 279,500 shares — an estimated $60.6M sold.

Paul Tudor Jones first reported a position in GWPH in Q4 2016 and held it in 2 quarters. The position peaked at $60.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Paul Tudor Jones reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Paul Tudor Jones sold 279,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $60.6M.
Paul Tudor Jones first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 2 quarters.
Paul Tudor Jones's GW Pharmaceuticals Plc American Depositary Shares position peaked at $60.6M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.